David Kabakoff

David Kabakoff

Chairman chez NEXTCURE, INC.

Fortune : 138 789 $ au 31/03/2024

76 ans
Health Technology
Commercial Services
Health Services

Profil

David joined the HealthQuest team in 2012 to leverage decades of experience as an entrepreneur in the diagnostics and biotech fields.
While a chemist by training, the companies that David has led as President, CEO or Chairman have produced billions of dollars in returns for investors and employees.
David brings over 44 years of industry experience to HealthQuest (14 of which have been in healthcare investing), and currently serves on the Board of portfolio company RareCyte, and previously served on the Boards of Lineagen (sold to Bionanogenomics), Biotheranostics (sold to Hologic) and Castle Biosciences (CSTL).
As an operator David’s successes include leading the development of some of the diagnostic industry’s most iconic products like the first yes/no color changing pregnancy test, the PSA test for prostate cancer and the rapid strep throat test, plus numerous cancer diagnostics.
He served in senior executive positions at Hybritech, was President of Dura Pharmaceuticals, CEO of Spiros Development Corp., Corvas International and co-founder/CEO of Salmedix.
Each of the products he developed succeeded because it made a large impact on the medical management of patients and David keeps a keen eye out for innovative products when he considers investments for HealthQuest.
He has served as Chairman of Trius Therapeutics (acquired by Cubist), Chairman of Cebix Inc., Chairman of Amplimmune, Inc. (acquired by AstraZeneca), and as a Director of InterMune, Inc. (acquired by Roche), Principia Biopharma (acquired by Sanofi), and Allylix, Inc. (acquired by Evolva).
David earned his BA in chemistry from Case Western Reserve University and then his PhD from Yale University.
He lives with his wife and enjoys fine wine, print collecting, skiing and golf.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
22/06/2023 62 237 ( 0,22% ) 138 789 $ 31/03/2024

Postes actifs de David Kabakoff

SociétésPosteDébut
NEXTCURE, INC. Chairman 01/12/2015
Private Equity Investor 01/01/2009
Director/Board Member -
Director/Board Member -
Director/Board Member 18/09/2018
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Tous les postes actifs de David Kabakoff

Anciens postes connus de David Kabakoff

SociétésPosteFin
░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de David Kabakoff

Formation de David Kabakoff

Case Western Reserve University Undergraduate Degree
Yale University Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de David Kabakoff

Relations

100 +

Relations au 1er degré

30

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
CASTLE BIOSCIENCES, INC.

Health Technology

NEXTCURE, INC.

Health Technology

Entreprise privées26

Health Technology

Corvas International, Inc.

Health Technology

Spiros Development Corp II, Inc.

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Miscellaneous

Health Technology

Health Technology

Finance

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. David Kabakoff